<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the patient with cutaneous blisters</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the patient with cutaneous blisters</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the patient with cutaneous blisters</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher Hull, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John J Zone, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Erik Stratman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H35462837"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cutaneous blisters occur in a wide variety of clinical settings, including autoimmune disorders, drug reactions, infections, genetic disorders, and physical injury. The ability to narrow the differential diagnosis for patients with blistering skin lesions is essential for the prompt recognition of life-threatening disorders and the appropriate management of other blistering diseases  (<a class="graphic graphic_algorithm graphicRef103314" href="/z/d/graphic/103314.html" rel="external">algorithm 1</a>).</p><p>The clinical approach to the diagnosis of disorders that present with cutaneous blisters and a summary of common investigative tests used to assist with diagnosis is discussed here. Blistering disorders in the newborn infant and specific blistering disorders are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant"</a>.)</p><p class="headingAnchor" id="H48262289"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>Blistering skin disorders are characterized by the presence of fluid-filled lesions on the skin that occur as a result of a loss of adhesion between cells within the epidermis (<strong>acantholysis</strong>), edema between epidermal cells (<strong>spongiosis</strong>), or disassociation of the epidermis and dermis. Pathologic events that may lead to the formation of blisters include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disruption of cellular or extracellular adhesion molecules</strong> (eg, autoimmune blistering disorders, congenital epidermolysis bullosa)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidermal cell injury or death</strong> (eg, toxic epidermal necrolysis, erythema multiforme)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Accumulation of excessive edema (spongiosis) within the epidermis</strong> (eg, contact dermatitis, acute and chronic vesicular palmoplantar dermatitis)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Traumatic injury</strong> (eg, friction or coma blisters)</p><p></p><p>Specific terms are used to describe cutaneous blisters based upon lesion size. <strong>Vesicles</strong> are usually designated as lesions that are less than 1 cm in diameter  (<a class="graphic graphic_picture graphicRef72210" href="/z/d/graphic/72210.html" rel="external">picture 1A</a>). In contrast, <strong>bullae</strong> are classified as lesions that are greater than 1 cm in size  (<a class="graphic graphic_picture graphicRef57569" href="/z/d/graphic/57569.html" rel="external">picture 2</a>).</p><p>The watery clear fluid content of vesicles and bullae distinguishes these lesions from pustules, which contain thicker, yellow-white purulent material (see  <a class="medical medical_review" href="/z/d/html/1733.html" rel="external">"Approach to the patient with pustular skin lesions"</a>). Although the clear fluid contents of vesicles and bullae may develop a more turbid quality over time, the watery quality is retained and such lesions are still easily distinguished from pustules. In cases in which blister formation is associated with damage to the blood vessels in the dermis, red blood cells may enter the blister cavity, resulting in red-colored blister fluid. The term "<strong>hemorrhagic blister</strong>" is used to refer to such lesions.</p><p>Blisters may occur at a variety of histologic locations within the skin. The location in which blisters form is often useful for diagnosis and can be determined via histopathologic examination  (<a class="graphic graphic_table graphicRef74129" href="/z/d/graphic/74129.html" rel="external">table 1</a>). The general categories used to describe the location of blister formation include [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intracorneal or subcorneal </strong>– Cleavage plane within the stratum corneum or immediately beneath the stratum corneum (eg, pemphigus foliaceus, staphylococcal scalded skin syndrome)  (<a class="graphic graphic_picture graphicRef57313" href="/z/d/graphic/57313.html" rel="external">picture 3</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraepidermal </strong>– Cleavage plane within the malpighian layer of the epidermis, excluding subcorneal and suprabasilar disorders (eg, contact dermatitis, viral infections)  (<a class="graphic graphic_picture graphicRef82841 graphicRef82840" href="/z/d/graphic/82841.html" rel="external">picture 4A-B</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suprabasilar </strong>– Cleavage plane within the epidermis with only an intact basal layer  (<a class="graphic graphic_picture graphicRef60749" href="/z/d/graphic/60749.html" rel="external">picture 5A</a>) (eg, pemphigus vulgaris, paraneoplastic pemphigus)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subepidermal </strong>– Cleavage plane within or below the basement membrane zone  (<a class="graphic graphic_picture graphicRef66267" href="/z/d/graphic/66267.html" rel="external">picture 5B</a>) (eg, bullous pemphigoid, porphyria cutanea tarda)</p><p></p><p>The clinical features of a blistering disorder often correlate with the histopathologic subtype. Whereas subcorneal blistering disorders tend to present with extremely fragile blisters that quickly evolve to scale, erosions, and desquamation, slightly less fragile flaccid vesicles or bullae are characteristic of intraepidermal or suprabasilar blisters. Lastly, tense bullae are typically seen in subepidermal blistering disorders due to the relatively greater proportion of epidermis overlying the blister cavity.</p><p class="headingAnchor" id="H4714603"><span class="h1">LIFE-THREATENING EMERGENCIES</span><span class="headingEndMark"> — </span>Several blistering disorders represent potentially life-threatening emergencies, warranting the need for early diagnosis and therapy. These include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Toxic epidermal necrolysis </strong>– Widespread sloughing of skin and severe mucositis in this disorder are associated with risk for sepsis  (<a class="graphic graphic_picture graphicRef67632 graphicRef68458 graphicRef59418" href="/z/d/graphic/67632.html" rel="external">picture 6A-C</a>). (See <a class="local">'Generalized blisters with systemic illness'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Staphylococcal scalded skin syndrome </strong>– A high mortality rate occurs in adults with this disorder  (<a class="graphic graphic_picture graphicRef80198 graphicRef72261" href="/z/d/graphic/80198.html" rel="external">picture 7A-B</a>). (See <a class="local">'Generalized blisters with systemic illness'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disseminated herpes simplex or herpes zoster infection in immunocompromised patients</strong> – May result in life-threatening internal complications  (<a class="graphic graphic_picture graphicRef77688" href="/z/d/graphic/77688.html" rel="external">picture 8</a>). (See <a class="local">'Generalized blisters with systemic illness'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Purpura fulminans </strong>– Although retiform purpura are the primary feature of purpura fulminans, associated necrotic bullae may also be present  (<a class="graphic graphic_picture graphicRef57103" href="/z/d/graphic/57103.html" rel="external">picture 9</a>). (See  <a class="medical medical_review" href="/z/d/html/16556.html" rel="external">"Approach to the patient with retiform (angulated) purpura", section on 'Recognition of life-threatening emergencies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Vibrio vulnificus</em></strong><strong> infection</strong> – Hemorrhagic or nonhemorrhagic bullae may occur in <em>Vibrio vulnificus</em> wound infections. <em>V. vulnificus</em> infection can rapidly progress to necrotizing soft tissue infections. (See  <a class="medical medical_review" href="/z/d/html/3128.html" rel="external">"Vibrio vulnificus infection", section on 'Clinical manifestations'</a>.)</p><p></p><p class="headingAnchor" id="H35462844"><span class="h1">PATIENT ASSESSMENT</span><span class="headingEndMark"> — </span>Blistering skin lesions can present a diagnostic challenge since the differential diagnosis is vast. The recognition of the distribution of the lesions is a useful clinical tool to begin to narrow the differential diagnosis  (<a class="graphic graphic_algorithm graphicRef103314" href="/z/d/graphic/103314.html" rel="external">algorithm 1</a>). A thorough patient history, the identification of additional clinical features, and pathologic and laboratory studies are often of additional value.</p><p>Examples of questions that may be useful during the assessment of the patient with cutaneous blisters include:</p><p class="bulletIndent1"><span class="glyph">●</span>Where are the lesions located (generalized, localized, specific sites)?</p><p class="bulletIndent1"><span class="glyph">●</span>Are mucous membranes involved?</p><p class="bulletIndent1"><span class="glyph">●</span>What is the size and configuration of blisters?</p><p class="bulletIndent1"><span class="glyph">●</span>If bullae are present, are they flaccid or tense?</p><p class="bulletIndent1"><span class="glyph">●</span>What is the patient's age?</p><p class="bulletIndent1"><span class="glyph">●</span>Does the patient have a history of exposure to a new medication?</p><p></p><p class="headingAnchor" id="H320145"><span class="h2">Lesion distribution</span><span class="headingEndMark"> — </span>The identification of cutaneous blisters as generalized, localized, or associated with mucous membrane involvement can offer valuable clues for diagnosis  (<a class="graphic graphic_table graphicRef60255 graphicRef82490 graphicRef67630" href="/z/d/graphic/60255.html" rel="external">table 2A-C</a>).</p><p class="headingAnchor" id="H32804617"><span class="h3">Generalized distribution</span></p><p class="headingAnchor" id="H32804630"><span class="h4">Generalized blisters with systemic illness</span><span class="headingEndMark"> — </span>Acute or chronic signs or symptoms of systemic illness are frequent features of several disorders that present with generalized blisters.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stevens-Johnson syndrome and toxic epidermal necrolysis </strong>– Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN) are acute, severe disorders characterized by epidermal sloughing of the skin and mucous membranes. These conditions most commonly occur as a result of exposure to an inciting medication [<a href="#rid2">2</a>]. Following a brief prodromal period of fever and flu-like symptoms, patients develop painful erythematous and purpuric macules or areas of diffuse macular erythema that progress to vesicles, bullae, and skin sloughing  (<a class="graphic graphic_picture graphicRef67632 graphicRef68458 graphicRef59418 graphicRef68682" href="/z/d/graphic/67632.html" rel="external">picture 6A-D</a>). The extent of body surface area involvement differentiates Stevens-Johnson syndrome (&lt;10 percent) from TEN (&gt;30 percent). Skin biopsies of fully developed lesions demonstrate epidermal-dermal separation and full-thickness epidermal necrosis. (See  <a class="medical medical_review" href="/z/d/html/2091.html" rel="external">"Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Staphylococcal scalded skin syndrome </strong>– Staphylococcal scalded syndrome occurs as a reaction to toxin released by <em>Staphylococcus aureus</em>, and most commonly occurs in infants, young children, and adults with renal failure [<a href="#rid3">3</a>]. Fever, malaise, and skin tenderness typically precede the eruption. The fragile subcorneal bullae often demonstrate the appearance of wrinkled skin with subsequent desquamation  (<a class="graphic graphic_picture graphicRef80198 graphicRef72261 graphicRef50249" href="/z/d/graphic/80198.html" rel="external">picture 7A-C</a>). Examination of a frozen tissue specimen of sloughed epidermis can be used to rapidly distinguish staphylococcal scalded skin from the epidermal sloughing of toxic epidermal necrolysis. Frozen sections taken from staphylococcal scalded skin syndrome demonstrate cleavage at the granular layer, whereas full-thickness epidermal necrosis and cleavage at the dermal-epidermal junction characterize toxic epidermal necrolysis. The site of the primary staphylococcal infection also should be identified. (See  <a class="medical medical_review" href="/z/d/html/114922.html" rel="external">"Staphylococcal scalded skin syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Varicella zoster virus infection </strong>– Varicella (chicken pox) is a disorder that most frequently occurs in children who are not vaccinated against the disease. Patients experience a prodrome of fever and malaise followed by the development of a generalized eruption of 1 to 3 mm intraepidermal or subepidermal vesicles surrounded by erythema. These lesions are often described as "dew drops on a rose petal," and subsequently evolve to form pustules and crusts  (<a class="graphic graphic_picture graphicRef72210 graphicRef94664" href="/z/d/graphic/72210.html" rel="external">picture 1A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/8284.html" rel="external">"Clinical features of varicella-zoster virus infection: Chickenpox"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disseminated herpes zoster </strong>– Disseminated herpes zoster can occur in immunocompromised patients. Unlike classic herpes zoster, the vesicular lesions are not restricted to a dermatome  (<a class="graphic graphic_picture graphicRef77688" href="/z/d/graphic/77688.html" rel="external">picture 8</a>). Disseminated herpes zoster may also result in life-threatening infection including pneumonia, hepatitis, encephalitis, or other organ involvement. (See  <a class="medical medical_review" href="/z/d/html/8327.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes zoster", section on 'Special considerations in immunocompromised hosts'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disseminated herpes simplex virus </strong>–<strong> </strong>Immunocompromised patients and patients with a compromised skin barrier (eg, atopic dermatitis, Darier disease) may develop widespread vesicles, pustules, and crusts due to herpes simplex virus infection. The term eczema herpeticum is used to describe this occurrence in patients with atopic dermatitis  (<a class="graphic graphic_picture graphicRef62779 graphicRef74838" href="/z/d/graphic/62779.html" rel="external">picture 10A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sweet syndrome (acute febrile neutrophilic dermatosis) </strong>–<strong> </strong>Although edematous, erythematous plaques with a pseudovesicular quality are most characteristic of Sweet syndrome, the plaques occasionally exhibit frank vesicle or bulla formation  (<a class="graphic graphic_picture graphicRef50526 graphicRef62314" href="/z/d/graphic/50526.html" rel="external">picture 11A-B</a>). The plaques are most frequently found on the upper body; fever and leukocytosis are also typically present. Sweet syndrome may occur in the setting of malignancy, infection, drug exposure, autoimmune disease, or inflammatory bowel disease. (See  <a class="medical medical_review" href="/z/d/html/13784.html" rel="external">"Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous systemic lupus erythematosus </strong>– Bullous systemic lupus erythematosus presents as widespread, tense, subepidermal bullae in patients with systemic lupus erythematosus. The skin lesions may resemble bullous pemphigoid or dermatitis herpetiformis  (<a class="graphic graphic_picture graphicRef66048" href="/z/d/graphic/66048.html" rel="external">picture 12</a>) [<a href="#rid4">4</a>]. Antibodies against type VII collagen have been associated with this disease. (See  <a class="medical medical_review" href="/z/d/html/109445.html" rel="external">"Bullous systemic lupus erythematosus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Paraneoplastic pemphigus </strong>– Paraneoplastic pemphigus is an uncommon mucocutaneous suprabasilar or subepidermal blistering disorder that occurs in the setting of malignancy. Stomatitis is characteristically severe  (<a class="graphic graphic_picture graphicRef59594" href="/z/d/graphic/59594.html" rel="external">picture 13</a>), but the morphology of skin lesions is variable [<a href="#rid5">5</a>]. In some cases, the skin lesions may resemble blisters of pemphigus vulgaris or erythema multiforme  (<a class="graphic graphic_picture graphicRef67265 graphicRef79192" href="/z/d/graphic/67265.html" rel="external">picture 14A-B</a>). Non-Hodgkin lymphoma, chronic lymphocytic leukemia, and Castleman's disease are the conditions most commonly associated with this disorder [<a href="#rid5">5</a>]. Serologic testing reveals reactivity with multiple antigens, including desmoplakins, desmogleins, and bullous pemphigoid antigen 1 (BPAg1, BP230) [<a href="#rid6">6,7</a>]. (See  <a class="medical medical_review" href="/z/d/html/15305.html" rel="external">"Paraneoplastic pemphigus"</a>.)</p><p></p><p class="headingAnchor" id="H32805760"><span class="h4">Other generalized blistering disorders</span><span class="headingEndMark"> — </span>Examples of generalized blistering disorders that are not necessarily associated with systemic illness are listed below:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Miliaria crystallina </strong>–<strong> </strong>Miliaria crystallina results from the obstruction of the ducts of eccrine sweat glands and usually occurs in the setting of excessive warmth. The fragile intracorneal or subcorneal 1 mm vesicles typically occur on the face and trunk  (<a class="graphic graphic_picture graphicRef76069" href="/z/d/graphic/76069.html" rel="external">picture 15</a>). (See  <a class="medical medical_review" href="/z/d/html/13733.html" rel="external">"Miliaria"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous impetigo </strong>–<strong> </strong>Subcorneal vesicles and bullae containing clear or yellow fluid on the face, trunk, perineum, or extremities characterize bullous impetigo, a disorder that most frequently occurs in neonates and children  (<a class="graphic graphic_picture graphicRef63992" href="/z/d/graphic/63992.html" rel="external">picture 16</a>). The bullae rupture easily, leaving erosions with a collarette of scale. (See  <a class="medical medical_review" href="/z/d/html/7655.html" rel="external">"Impetigo", section on 'Bullous impetigo'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pemphigus </strong>– The formation of flaccid bullae that quickly evolve to erosions are typical of pemphigus vulgaris  (<a class="graphic graphic_picture graphicRef53425" href="/z/d/graphic/53425.html" rel="external">picture 17</a>) [<a href="#rid8">8</a>]. Mucous membrane vesicles and erosions are a frequent associated finding  (<a class="graphic graphic_picture graphicRef57924 graphicRef77462" href="/z/d/graphic/57924.html" rel="external">picture 18A-B</a>). The level of blister formation in pemphigus vulgaris is suprabasilar. By contrast, the most prominent feature of pemphigus foliaceus, a subcorneal blistering disorder, is erythematous plaques with overlying scale or crust  (<a class="graphic graphic_picture graphicRef54341 graphicRef72419" href="/z/d/graphic/54341.html" rel="external">picture 19A-B</a>). These patients do not develop mucosal blisters. (See  <a class="medical medical_review" href="/z/d/html/83684.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of pemphigus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous pemphigoid</strong> – Bullous pemphigoid is a subepidermal blistering disorder that most commonly occurs in older adults  (<a class="graphic graphic_picture graphicRef78910 graphicRef72866" href="/z/d/graphic/78910.html" rel="external">picture 20A-B</a>) [<a href="#rid9">9</a>]. The classic skin lesions are urticarial plaques and tense bullae on the trunk and extremities. Intense pruritus is common, and lesions typically do not scar. Localized forms of bullous pemphigoid may also occur [<a href="#rid10">10</a>]. Bullous pemphigoid patients may also develop mucosal involvement. (See  <a class="medical medical_review" href="/z/d/html/16176.html" rel="external">"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pemphigoid gestationis </strong>– Pemphigoid gestationis is a subepidermal blistering disorder that occurs during pregnancy or in the immediate postpartum period. Urticarial plaques and vesicles typically begin around the umbilicus prior to spreading elsewhere with large bulla formation  (<a class="graphic graphic_picture graphicRef78383 graphicRef52776 graphicRef72690" href="/z/d/graphic/78383.html" rel="external">picture 21A-C</a>). (See  <a class="medical medical_review" href="/z/d/html/5564.html" rel="external">"Dermatoses of pregnancy", section on 'Pemphigoid gestationis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Linear IgA bullous dermatosis </strong>– Linear IgA bullous dermatosis is a subepidermal blistering disorder associated with the deposition of IgA at the basement membrane zone of skin and mucosal tissues [<a href="#rid11">11</a>]. This disorder may occur as a primary autoimmune disease or as a drug reaction. The cutaneous bullae often have a distinctive grouped appearance that resembles a cluster of jewels  (<a class="graphic graphic_picture graphicRef56434" href="/z/d/graphic/56434.html" rel="external">picture 22</a>). The term chronic bullous disease of childhood is used to refer to this disorder in children. (See  <a class="medical medical_review" href="/z/d/html/15301.html" rel="external">"Linear IgA bullous dermatosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermatitis herpetiformis </strong>– Dermatitis herpetiformis is a cutaneous manifestation of gluten sensitivity that presents with grouped vesicles and excoriated papules with a predilection for the extensor extremities, scalp, and buttocks  (<a class="graphic graphic_picture graphicRef78315" href="/z/d/graphic/78315.html" rel="external">picture 23</a>) [<a href="#rid12">12,13</a>]. The lesions of this subepidermal blistering disorder are intensely pruritic. (See  <a class="medical medical_review" href="/z/d/html/15307.html" rel="external">"Dermatitis herpetiformis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidermolysis bullosa </strong>– Congenital epidermolysis bullosa is a rare genetic disorder that consists of multiple variants. Depending on the type of epidermolysis bullosa, lesions may be intraepidermal or subepidermal, localized or generalized, and detected as early as birth or not until adulthood  (<a class="graphic graphic_picture graphicRef68938" href="/z/d/graphic/68938.html" rel="external">picture 24</a>). (See  <a class="medical medical_review" href="/z/d/html/15449.html" rel="external">"Epidermolysis bullosa: Epidemiology, pathogenesis, classification, and clinical features"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidermolysis bullosa acquisita </strong>– Epidermolysis bullosa acquisita is a rare, acquired subepidermal blistering disorder that may affect both skin and mucous membranes  (<a class="graphic graphic_picture graphicRef62505" href="/z/d/graphic/62505.html" rel="external">picture 25</a>). Tense bullae, scarring, and milia formation are common associated features. Antibodies against type VII collagen are pathogenic in this disease and can be measured in serum [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/z/d/html/15299.html" rel="external">"Epidermolysis bullosa acquisita"</a>.)</p><p></p><p class="headingAnchor" id="H32804610"><span class="h3">Localized distribution</span><span class="headingEndMark"> — </span>The recognition that blisters are primarily located in certain body locations, such as dependent areas, acral areas, or sun-exposed skin may assist with diagnosis  (<a class="graphic graphic_table graphicRef82490" href="/z/d/graphic/82490.html" rel="external">table 2B</a> and <a class="graphic graphic_algorithm graphicRef103314" href="/z/d/graphic/103314.html" rel="external">algorithm 1</a>). In addition, a linear distribution of skin lesions suggests the possibility of an external insult as the cause of blistering.</p><p class="headingAnchor" id="H32804638"><span class="h4">Dependent areas</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coma blisters </strong>– Coma blisters are tense, subepidermal bullae that have been reported to occur in sites of pressure in comatose patients. These lesions have been associated with exposure to drugs (eg, opiates, tricyclic antidepressants, antipsychotics) and a variety of medical conditions, such as chronic renal failure, diabetic ketoacidosis, hyperparathyroidism, and neurologic disease [<a href="#rid15">15</a>]. Erythematous or ecchymotic patches or plaques may precede the development of bullous lesions. The blisters spontaneously resolve within two to four weeks [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous disease of diabetes (bullosis diabeticorum) </strong>– Bullous disease of diabetes is a term used to describe the abrupt development of noninflammatory, tense, subepidermal bullae in patients with diabetes in sites of otherwise normal-appearing skin  (<a class="graphic graphic_picture graphicRef57569" href="/z/d/graphic/57569.html" rel="external">picture 2</a>) [<a href="#rid16">16</a>]. Lesions most commonly occur on the feet or lower legs and may be up to several centimeters in diameter. The bullae spontaneously resolve over the course of a few weeks. The term bullous diabeticorum has also been used to refer to this disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous leukocytoclastic vasculitis </strong>–<strong> </strong>Hemorrhagic vesicles or bullae may occur among the purpuric macules, papules, or plaques of cutaneous leukocytoclastic vasculitis  (<a class="graphic graphic_picture graphicRef57440" href="/z/d/graphic/57440.html" rel="external">picture 26</a>). Necrosis of the skin overlying areas of small vessel vasculitis leads to the development of these subepidermal bullous lesions. (See  <a class="medical medical_review" href="/z/d/html/13769.html" rel="external">"Evaluation of adults with cutaneous lesions of vasculitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Edema (stasis) blisters </strong>– Bullae may form in areas of edema. These asymptomatic lesions often occur on the lower legs and resolve upon resolution of the cause of edema  (<a class="graphic graphic_picture graphicRef78581" href="/z/d/graphic/78581.html" rel="external">picture 27</a>) [<a href="#rid15">15</a>]. There is little published information on edema blisters, and it is not definitively known whether the majority of these blisters are subepidermal or intraepidermal. (See  <a class="medical medical_review" href="/z/d/html/13670.html" rel="external">"Stasis dermatitis", section on 'Clinical presentation'</a>.)</p><p></p><p class="headingAnchor" id="H4098888672"><span class="h4">Hands or feet</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute palmoplantar (dyshidrotic) eczema </strong>– Intensely pruritic vesicles or bullae on the hands or feet are consistent with this disorder  (<a class="graphic graphic_picture graphicRef55722 graphicRef83007" href="/z/d/graphic/55722.html" rel="external">picture 28A-B</a>). The palms, soles, and sides of the digits are typical sites for involvement. Spongiotic intraepidermal vesicles are present on histopathologic examination. (See  <a class="medical medical_review" href="/z/d/html/13657.html" rel="external">"Acute palmoplantar eczema (dyshidrotic eczema)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermatophytosis </strong>–<strong> </strong>Blistering tinea pedis is most often associated with <em>Trichophyton mentagrophytes</em> or <em>Epidermophyton floccosum</em> infection [<a href="#rid17">17</a>]. The associated intraepidermal spongiotic vesicles and bullae are often present on the soles or between the toes  (<a class="graphic graphic_picture graphicRef54214" href="/z/d/graphic/54214.html" rel="external">picture 29</a>). In addition, dermatophytid reactions (autoeczematization or id reactions that occur in the setting of dermatophyte infection) may result in vesicular eruptions on the hands  (<a class="graphic graphic_picture graphicRef52664" href="/z/d/graphic/52664.html" rel="external">picture 30</a>). (See  <a class="medical medical_review" href="/z/d/html/4030.html" rel="external">"Dermatophyte (tinea) infections", section on 'Tinea pedis'</a> and  <a class="medical medical_review" href="/z/d/html/4030.html" rel="external">"Dermatophyte (tinea) infections", section on 'Id reactions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Friction blister </strong>–<strong> </strong>Friction blisters are intraepidermal blisters that result from trauma-induced separation within the epidermis. They most frequently occur on the heels and soles of the feet due to friction from shoes during walking or running. The possibility of epidermolysis bullosa simplex should be considered in patients with frequent and excessive blistering. (See  <a class="medical medical_review" href="/z/d/html/112564.html" rel="external">"Friction blisters"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sucking blisters </strong>– Blisters on the hands or feet due to intrauterine sucking may be detected in neonates  (<a class="graphic graphic_picture graphicRef67302 graphicRef78479" href="/z/d/graphic/67302.html" rel="external">picture 31A-B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Erythema multiforme </strong>– The acral extremities are a site of predilection for lesions of erythema multiforme, a disorder that most commonly occurs in association with herpes simplex virus infection. The classic dusky erythematous target lesions of erythema multiforme may exhibit a central subepidermal blister  (<a class="graphic graphic_picture graphicRef79955" href="/z/d/graphic/79955.html" rel="external">picture 32</a>). Mucosal involvement is also frequently present  (<a class="graphic graphic_picture graphicRef75314 graphicRef58969" href="/z/d/graphic/75314.html" rel="external">picture 33A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/5559.html" rel="external">"Erythema multiforme: Pathogenesis, clinical features, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Localized epidermolysis bullosa simplex </strong>– Localized epidermolysis bullosa simplex (formerly known as the Weber-Cockayne variant of epidermolysis bullosa simplex) is a rare autosomal dominant genetic disorder in which intraepidermal blisters form in sites of friction or trauma. The hands and feet are frequently affected  (<a class="graphic graphic_picture graphicRef59364 graphicRef73201" href="/z/d/graphic/59364.html" rel="external">picture 34A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/15449.html" rel="external">"Epidermolysis bullosa: Epidemiology, pathogenesis, classification, and clinical features", section on 'Localized epidermolysis bullosa simplex'</a>.)</p><p></p><p class="headingAnchor" id="H32804646"><span class="h4">Photodistributed</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Polymorphous light eruption </strong>– Polymorphous light eruption is a fairly common disorder that usually develops within hours of sun exposure. Although the most common manifestations are pruritic erythematous papules or plaques, vesicles or bullae may also occur as a manifestation of extensive dermal edema  (<a class="graphic graphic_picture graphicRef64270" href="/z/d/graphic/64270.html" rel="external">picture 35</a>). (See  <a class="medical medical_review" href="/z/d/html/6623.html" rel="external">"Polymorphous light eruption"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Porphyria cutanea tarda </strong>– Photosensitivity is a key feature of porphyria cutanea tarda, an inherited or acquired metabolic disorder that may present with the formation of predominantly noninflammatory vesicles and bullae  (<a class="graphic graphic_picture graphicRef74528 graphicRef78547" href="/z/d/graphic/74528.html" rel="external">picture 36A-B</a>). Sun-exposed areas are typically affected. The dorsal hands and forearms are common sites of involvement, and crusts, scars, and milia are often present. Other cutaneous features of porphyria cutanea tarda include hyperpigmentation, hypertrichosis, and localized sclerodermoid plaques [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/z/d/html/7108.html" rel="external">"Porphyria cutanea tarda and hepatoerythropoietic porphyria: Pathogenesis, clinical manifestations, and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pseudoporphyria </strong>– Although pseudoporphyria presents with clinical and histopathologic features that resemble porphyria cutanea tarda, abnormalities of porphyrin metabolism are absent. Like porphyria cutanea tarda, subepidermal bullae, crusts, and scarring on the dorsal hands are common clinical findings  (<a class="graphic graphic_picture graphicRef80856" href="/z/d/graphic/80856.html" rel="external">picture 37</a>). A number of medications have been associated with this condition [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/z/d/html/13748.html" rel="external">"Pseudoporphyria"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sunburn and phototoxic reactions </strong>–<strong> </strong>Severe sunburns can result in blister formation on the skin  (<a class="graphic graphic_picture graphicRef52112" href="/z/d/graphic/52112.html" rel="external">picture 38</a>). Phototoxic eruptions, which usually occur due to sun exposure after ingestion of a photosensitizing drug, resemble sunburns and can also present with blistering. (See  <a class="medical medical_review" href="/z/d/html/6624.html" rel="external">"Sunburn"</a> and  <a class="medical medical_review" href="/z/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Phototoxicity'</a>.)</p><p></p><p class="headingAnchor" id="H323939"><span class="h4">Dermatomal</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Herpes zoster </strong>– Herpes zoster (shingles) presents with a grouped eruption of painful intraepidermal vesicles in a dermatomal distribution  (<a class="graphic graphic_picture graphicRef81443 graphicRef58282" href="/z/d/graphic/81443.html" rel="external">picture 39A-B</a>). In immunocompromised patients, disseminated lesions may occur. (See  <a class="medical medical_review" href="/z/d/html/8327.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes zoster"</a>.)</p><p></p><p class="headingAnchor" id="H32804661"><span class="h4">Linear distribution</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contact dermatitis </strong>– Intensely pruritic dermatitis and intraepidermal spongiotic bullae often develop in patients with severe contact dermatitis, such as can occur after exposure to poison ivy  (<a class="graphic graphic_picture graphicRef101005" href="/z/d/graphic/101005.html" rel="external">picture 40</a>). Lesions develop in sites of contact of the inciting substance with the skin. A linear distribution is common. (See  <a class="medical medical_review" href="/z/d/html/13655.html" rel="external">"Clinical features and diagnosis of allergic contact dermatitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phytophotodermatitis </strong>–<strong> </strong>Erythema, edema, and vesiculation occurring in a linear or odd configuration may develop after topical exposure to certain of plant-derived substances (eg, lemons, limes, celery, wild parsnip, or parsley) followed by sun exposure  (<a class="graphic graphic_picture graphicRef57871 graphicRef81457" href="/z/d/graphic/57871.html" rel="external">picture 41A-B</a>) [<a href="#rid20">20</a>]. The term "berloque dermatitis" has been used to refer to lesions secondary to natural oil of bergamot in products used on the skin. Significant postinflammatory hyperpigmentation after resolution of the acute process is common. (See  <a class="medical medical_review" href="/z/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Phytophotodermatitis'</a>.)</p><p></p><p class="headingAnchor" id="H32804669"><span class="h4">Other localized blistering disorders</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Herpes simplex virus </strong>– A localized eruption composed of grouped, small, often umbilicated vesicles or vesicopustules is characteristic of herpes simplex virus infection  (<a class="graphic graphic_picture graphicRef58485 graphicRef73975" href="/z/d/graphic/58485.html" rel="external">picture 42A-B</a>). The lips, genitals, and buttocks are common sites of involvement. Primary infections tend to be most severe and can be accompanied by lymphadenopathy and flu-like symptoms. Extensive lesions may occur in patients with atopic dermatitis, a condition referred to as eczema herpeticum (also referred to as Kaposi's varicelliform eruption). (See  <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection"</a> and  <a class="medical medical_review" href="/z/d/html/8347.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous arthropod bite </strong>– Occasionally, vesicles and bullae occur at sites of arthropod bites  (<a class="graphic graphic_picture graphicRef52794 graphicRef60230" href="/z/d/graphic/52794.html" rel="external">picture 43A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/4088.html" rel="external">"Insect and other arthropod bites"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fixed drug eruption </strong>–<strong> </strong>Central bullae may appear in lesions of fixed drug eruptions, which present as single or multiple dusky erythematous to violaceous round plaques  (<a class="graphic graphic_picture graphicRef67733" href="/z/d/graphic/67733.html" rel="external">picture 44</a>). The lips, genitalia, face, and acral areas are common sites of involvement. The lesions tend to heal with significant postinflammatory hyperpigmentation and typically recur in the same sites with subsequent drug exposure. (See  <a class="medical medical_review" href="/z/d/html/15760.html" rel="external">"Fixed drug eruption"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transient acantholytic dermatosis (Grover's disease) </strong>–<strong> </strong>Transient acantholytic dermatosis is a disorder that is most commonly detected in middle-aged White men. Pruritic, erythematous papules and papulovesicles are typically localized to the trunk  (<a class="graphic graphic_picture graphicRef76504" href="/z/d/graphic/76504.html" rel="external">picture 45</a>). Acantholysis and dyskeratosis are evident on histopathologic examination of papulovesicular lesions. (See  <a class="medical medical_review" href="/z/d/html/5566.html" rel="external">"Grover's disease (transient and persistent acantholytic dermatosis)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hailey-Hailey disease </strong>– Hailey-Hailey disease is an uncommon genetic disorder that presents with fragile acantholytic blisters that quickly evolve to erosions that are primarily localized to the neck and intertriginous areas  (<a class="graphic graphic_picture graphicRef80862 graphicRef61689 graphicRef74552" href="/z/d/graphic/80862.html" rel="external">picture 46A-C</a>). Erythematous vegetative plaques develop in involved areas as the disease progresses. (See  <a class="medical medical_review" href="/z/d/html/15463.html" rel="external">"Hailey-Hailey disease (benign familial pemphigus)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous pyoderma gangrenosum </strong>–<strong> </strong>Atypical variants of pyoderma gangrenosum may present with subepidermal bullae in conjunction with superficial ulcers  (<a class="graphic graphic_picture graphicRef55967" href="/z/d/graphic/55967.html" rel="external">picture 47</a>). (See  <a class="medical medical_review" href="/z/d/html/13782.html" rel="external">"Pyoderma gangrenosum: Pathogenesis, clinical features, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Vibrio vulnificus</em></strong><strong> infection </strong>– Bullae, including hemorrhagic bullae, may occur in <em>V. vulnificus</em> wound infections  (<a class="graphic graphic_picture graphicRef63423" href="/z/d/graphic/63423.html" rel="external">picture 48</a>). These infections may progress to necrotizing soft tissue infection, bacteremia, and sepsis. (See  <a class="medical medical_review" href="/z/d/html/3128.html" rel="external">"Vibrio vulnificus infection"</a>.)</p><p></p><p class="headingAnchor" id="H32804576"><span class="h3">Mucous membrane involvement</span><span class="headingEndMark"> — </span>Many blistering eruptions may also have mucosal involvement. When blistering disorders involve the mucous membranes, frank vesicles and bullae often are not seen. Rather, mucosal inflammation or erosions tend to be the predominant clinical finding.</p><p>The following disorders are examples of blistering diseases that may present with both cutaneous and mucosal findings  (<a class="graphic graphic_table graphicRef67630" href="/z/d/graphic/67630.html" rel="external">table 2C</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mucous membrane pemphigoid </strong>–<strong> </strong>Mucous membrane pemphigoid (MMP) is defined as a diverse group of blistering disorders characterized by mucous membranes as the primary site of involvement. Inflamed, eroded, or scarred mucosa may be present  (<a class="graphic graphic_picture graphicRef52208 graphicRef63997 graphicRef75723 graphicRef54207 graphicRef77654" href="/z/d/graphic/52208.html" rel="external">picture 49A-E</a>). Cutaneous blisters accompany the mucosal lesions in some patients. (See  <a class="medical medical_review" href="/z/d/html/16176.html" rel="external">"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pemphigus vulgaris</strong> (see <a class="local">'Other generalized blistering disorders'</a> above).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Paraneoplastic pemphigus </strong>(see <a class="local">'Generalized blisters with systemic illness'</a> above).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bullous pemphigoid</strong> (see <a class="local">'Other generalized blistering disorders'</a> above).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Linear IgA bullous dermatosis</strong> (see <a class="local">'Other generalized blistering disorders'</a> above).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidermolysis bullosa acquisita</strong> (see <a class="local">'Other generalized blistering disorders'</a> above).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Erythema multiforme</strong> (see <a class="local">'Hands or feet'</a> above).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stevens-Johnson syndrome and toxic epidermolytic necrolysis</strong> (see <a class="local">'Generalized blisters with systemic illness'</a> above).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Herpes simplex virus infection</strong> (see <a class="local">'Other localized blistering disorders'</a> above).</p><p></p><p class="headingAnchor" id="H320485"><span class="h2">Additional clinical features</span><span class="headingEndMark"> — </span>In addition to the recognition of the distribution of cutaneous blisters, knowledge of the patient's age, blister characteristics, and the patient's drug history may help to narrow the differential diagnosis.</p><p class="headingAnchor" id="H320123"><span class="h3">Patient age</span><span class="headingEndMark"> — </span>Although patient age cannot be used to definitively exclude most blistering disorders, this information may provide additional clues for diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neonates </strong>– In neonates, blistering lesions can occur due to intrauterine or postpartum exposure to infections or trauma, congenital disorders, miliaria crystallina, or other disorders. The differential diagnosis for neonates with cutaneous blisters is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Young children </strong>– Disorders such as bullous impetigo and staphylococcal scalded skin occur with greater frequency in infants and young children than in other age populations.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Older adults </strong>– Pemphigus and pemphigoid occur with greater frequency in older adults than in younger individuals.</p><p></p><p class="headingAnchor" id="H320462"><span class="h3">Blister configuration</span><span class="headingEndMark"> — </span>Grouped blisters are characteristic of herpes simplex virus infection  (<a class="graphic graphic_picture graphicRef81443" href="/z/d/graphic/81443.html" rel="external">picture 39A</a>), herpes zoster  (<a class="graphic graphic_picture graphicRef58282" href="/z/d/graphic/58282.html" rel="external">picture 39B</a>), dermatitis herpetiformis  (<a class="graphic graphic_picture graphicRef78315" href="/z/d/graphic/78315.html" rel="external">picture 23</a>), and linear IgA bullous dermatosis. An annular configuration is often present in linear IgA bullous dermatosis  (<a class="graphic graphic_picture graphicRef56434" href="/z/d/graphic/56434.html" rel="external">picture 22</a>) and a linear arrangement of bullous lesions suggests the possibility of contact dermatitis or phytophotodermatitis.</p><p class="headingAnchor" id="H320477"><span class="h3">Blister size</span><span class="headingEndMark"> — </span>Small vesicles are the primary lesions in miliaria crystallina, acute palmoplantar eczema, herpes simplex virus or varicella zoster virus infection, and dermatitis herpetiformis.</p><p class="headingAnchor" id="H5172250"><span class="h3">Blister quality</span><span class="headingEndMark"> — </span>Tense blisters are a characteristic feature of subepidermal blistering disorders, such as bullous pemphigoid, pemphigoid gestationis, linear IgA bullous dermatosis, epidermolysis bullosa acquisita, and porphyria cutanea tarda. More flaccid blisters are typically seen in conditions in which the level of bulla formation is more superficial.</p><p class="headingAnchor" id="H5170792"><span class="h3">History of drug exposure</span><span class="headingEndMark"> — </span>Drug exposure is frequently associated with fixed drug eruptions, pseudoporphyria, Stevens-Johnson syndrome, toxic epidermal necrolysis, and linear IgA dermatosis  (<a class="graphic graphic_table graphicRef55836" href="/z/d/graphic/55836.html" rel="external">table 3</a>). Occasionally, erythema multiforme, pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid, and mucous membrane pemphigoid are linked to an inciting pharmacologic agent.</p><p class="headingAnchor" id="H320493"><span class="h2">Nikolsky sign</span><span class="headingEndMark"> — </span>The Nikolsky (or Nikolskiy) sign is a clinical finding that describes the elicitation of skin blistering as a result of gentle mechanical pressure on the skin. Depending on the clinical scenario, a positive Nikolsky sign may be observed at the edge of an existing lesion, in an area of normal-appearing skin, or in both locations [<a href="#rid21">21</a>].</p><p>The Nikolsky sign is often cited as a feature of the acantholytic, suprabasilar blistering disorder pemphigus vulgaris; however, the absence of this finding does not rule out this diagnosis. In addition, the Nikolsky sign has been detected in multiple blistering diseases with divergent modes of blister formation and levels of blister cleavage, including among them toxic epidermal necrolysis, staphylococcal scalded skin syndrome, and a subset of patients with bullous pemphigoid [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/83684.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of pemphigus", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H4714325"><span class="h1">DIAGNOSTIC TESTS</span><span class="headingEndMark"> — </span>Many blistering disorders share clinical features, and diagnostic tests are essential in differentiating these conditions and making an accurate diagnosis. The principle tests utilized in the evaluation of blistering diseases include light microscopy, direct immunofluorescence, indirect immunofluorescence, antigen-specific serologic testing, and microbiologic studies. The selection of the most appropriate studies to order is patient-specific and based upon the suspected diagnoses.</p><p class="headingAnchor" id="H4714350"><span class="h2">Skin biopsy</span><span class="headingEndMark"> — </span>A skin biopsy with or without direct immunofluorescence studies is often the first step in the evaluation of patients with an unknown skin blistering disorder.</p><p class="headingAnchor" id="H4714340"><span class="h3">Light microscopy</span><span class="headingEndMark"> — </span>Examination of a skin biopsy with light microscopy is useful for identifying the histopathologic features that characterize specific disorders. Light microscopy can detect the level of blister formation, the type of inflammatory cell infiltrate, the presence of dyskeratotic cells, and histopathologic features suggestive of infection  (<a class="graphic graphic_picture graphicRef60749 graphicRef66267" href="/z/d/graphic/60749.html" rel="external">picture 5A-B</a>).</p><p>Specimens for light microscopic examination are usually obtained from lesional tissue. If small vesicles are present, removal of an entire lesion is preferred. For larger lesions, the specimen should be obtained from the edge of a blister; the specimen should contain both portions of the blister and intact skin.</p><p>Punch biopsies are most frequently utilized for the evaluation of blistering lesions, as they allow for evaluation of the full thickness of the epidermis and dermis, which can be useful in cases in which dermal findings may offer additional clues for diagnosis. A deep shave biopsy that extends into the reticular dermis can also be utilized, but may result in a larger, scoop-like scar. Specimens for light microscopy can be placed in formalin for preservation. (See  <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">"Skin biopsy techniques", section on 'Punch biopsy'</a> and  <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">"Skin biopsy techniques", section on 'Shave biopsy'</a>.)</p><p class="headingAnchor" id="H4714358"><span class="h3">Direct immunofluorescence</span><span class="headingEndMark"> — </span>Direct immunofluorescence is a technique that allows for the detection of antibody or complement deposition within the skin. Direct immunofluorescence studies are typically utilized when an autoimmune blistering disorder is suspected. The recognition of the pattern and location of antibody binding can offer valuable insight for diagnosis. For example, intercellular antibody deposition in the epidermis characterizes pemphigus vulgaris and pemphigus foliaceus, whereas linear antibody deposition along the basement membrane zone is detected in bullous pemphigoid  (<a class="graphic graphic_picture graphicRef82837 graphicRef82838 graphicRef53466" href="/z/d/graphic/82837.html" rel="external">picture 50A-C</a>).</p><p>The specimen should be taken from normal-appearing skin adjacent to the blister, which is referred to as a <strong>perilesional </strong>biopsy. A biopsy of lesional skin is more likely to result in false negative results because of destruction of the immunoreactants by the inflammatory process. Tissue obtained for direct immunofluorescence should not be placed in formalin; rather, Michel's medium or Zeus medium can be used for preservation. Fresh specimens also may be sent to the laboratory, provided they are kept moist with <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>, and processing within 24 hours is feasible.</p><p>The basic procedure for direct immunofluorescence is as follows [<a href="#rid22">22</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Cut sections from the specimen are placed on microscope slides.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A solution containing antisera against IgG, IgA, IgM, complement factor C3, and fibrinogen conjugated to fluorescent dye is incubated with the sections.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The sections are subsequently washed and mounted for examination utilizing an epifluorescence microscope.</p><p></p><p class="headingAnchor" id="H320553"><span class="h2">Serologic tests</span><span class="headingEndMark"> — </span>Indirect immunofluorescence studies and antigen-specific serologic testing may be useful for the evaluation of autoimmune blistering disorders.</p><p class="headingAnchor" id="H4714372"><span class="h3">Indirect immunofluorescence</span><span class="headingEndMark"> — </span>Indirect immunofluorescence can be used to detect antibodies within the circulation. In this technique, the presence of antibodies in the patient's serum that are capable of binding to components of an epithelial specimen that is not from the patient is assessed  (<a class="graphic graphic_picture graphicRef82839" href="/z/d/graphic/82839.html" rel="external">picture 51</a>). Similar to direct immunofluorescence, this test is typically utilized to aid in the diagnosis of autoimmune blistering disease.</p><p>The basic procedure for indirect immunofluorescence is as follows [<a href="#rid22">22</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood is drawn from the patients and centrifuged to separate serum.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The selected substrate (eg, monkey esophagus, guinea pig esophagus, rat bladder, or human skin depending upon the suspected diagnosis) is incubated with progressive dilutions of patient serum.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The tissue is incubated with antibodies conjugated to a fluorescent dye that are directed against the antibodies bound to the substrate.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The slides are washed, mounted, and examined utilizing an epifluorescent microscope.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Results are reported as the limiting dilution in which specific fluorescence is detected.</p><p></p><p class="headingAnchor" id="H4714441"><span class="h3">Antigen-specific serologic testing</span><span class="headingEndMark"> — </span>If the target of circulating antibodies associated with specific autoimmune blistering diseases is known, antigen-specific testing can be used to detect the presence of antibodies in serum. Enzyme-linked immunosorbent assay (ELISA) is the most common test utilized and is frequently employed in disorders such as bullous pemphigoid, pemphigoid gestationis, and pemphigus vulgaris. Other antigen-specific serologic tests, such as immunoblotting and immunohistochemistry, have also been utilized for the diagnosis of autoimmune blistering diseases. These tests are more labor-intensive than ELISA, but may be the only way to definitively identify epidermolysis bullosa acquisita and laminin-332 pemphigoid. These disorders may be associated with inflammatory bowel disease or malignancy, respectively.</p><p class="headingAnchor" id="H320546"><span class="h2">Basement membrane zone-split skin technique</span><span class="headingEndMark"> — </span>Tissue specimens with an artificially induced cleavage zone between the epidermis and dermis (known as basement membrane zone-split skin or salt-split skin) are utilized to obtain more precise information on the localization of antibody binding within the basement membrane zone in direct and indirect immunofluorescence studies [<a href="#rid22">22</a>]. Incubation of the skin substrate in a 1 M sodium chloride (NaCl) or ethylenediaminetetraacetic acid (EDTA) solution induces separation at the level of the lamina lucida. The location of antibody binding to the epidermal (roof) or dermal (floor) side of the split can be used to further narrow the differential diagnosis  (<a class="graphic graphic_picture graphicRef82836" href="/z/d/graphic/82836.html" rel="external">picture 52</a>). (See  <a class="medical medical_review" href="/z/d/html/16176.html" rel="external">"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid", section on 'Confirmatory testing'</a>.)</p><p class="headingAnchor" id="H4714451"><span class="h2">Microbiologic studies</span><span class="headingEndMark"> — </span>If infection is suspected, microbiologic tests can be useful for diagnosis. A potassium hydroxide (KOH) preparation is a quick diagnostic test for bullous tinea pedis  (<a class="graphic graphic_picture graphicRef60102" href="/z/d/graphic/60102.html" rel="external">picture 53</a>). In addition, bacterial cultures of the blister site may aid in the diagnosis of bullous impetigo, and in staphylococcal scalded skin syndrome, culture of the potential sites of the primary staphylococcal infection can be of value. In patients with suspected herpes simplex virus or varicella zoster virus infection, studies such as Tzanck smear  (<a class="graphic graphic_picture graphicRef79784" href="/z/d/graphic/79784.html" rel="external">picture 54</a>), viral culture, polymerase chain reaction, and direct fluorescent antibody testing may be used to confirm a diagnosis. (See  <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">"Office-based dermatologic diagnostic procedures", section on 'Potassium hydroxide preparation'</a> and  <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">"Office-based dermatologic diagnostic procedures", section on 'Tzanck smear'</a>.)</p><p class="headingAnchor" id="H4714460"><span class="h1">INDICATIONS FOR REFERRAL</span><span class="headingEndMark"> — </span>Referral to a dermatologist is indicated if an autoimmune blistering disease is suspected, if the cause of blistering is unknown, or if the disease continues to progress despite appropriate treatment. Patients with suspected toxic epidermal necrolysis require immediate transfer to an experienced burn unit. Patients with staphylococcal scalded skin syndrome require hospital admission for intravenous antibiotic therapy. (See  <a class="medical medical_review" href="/z/d/html/2092.html" rel="external">"Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae"</a> and  <a class="medical medical_review" href="/z/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant", section on 'Staphylococcal scalded skin syndrome'</a>.)</p><p class="headingAnchor" id="H2946311"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/83674.html" rel="external">"Patient education: Blisters (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H4714632"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview </strong>– A wide variety of disorders can result in the formation of blisters on the skin. Autoimmune disorders, drug reactions, infections, genetic disorders, and traumatic injury are among the potential causes of cutaneous blistering. (See <a class="local">'Introduction'</a> above and <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histopathologic features </strong>– Cutaneous blisters may occur at various sites within the skin  (<a class="graphic graphic_table graphicRef74129" href="/z/d/graphic/74129.html" rel="external">table 1</a>). Blisters that form within the epidermis tend to be more fragile and flaccid than the tense blisters that are typically associated with subepidermal blistering diseases. (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Life-threatening emergencies </strong>– Life-threatening cutaneous blistering disorders include toxic epidermal necrolysis, staphylococcal scalded skin syndrome, disseminated herpes simplex virus infection, disseminated herpes zoster, purpura fulminans, and <em>Vibrio vulnificus</em> infection. Identification of these disorders should be prompt to reduce the risk of fatal complications. (See <a class="local">'Life-threatening emergencies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient assessment </strong>– The distribution of cutaneous blisters is often useful for narrowing the differential diagnosis  (<a class="graphic graphic_table graphicRef60255 graphicRef82490 graphicRef67630" href="/z/d/graphic/60255.html" rel="external">table 2A-C</a> and <a class="graphic graphic_algorithm graphicRef103314" href="/z/d/graphic/103314.html" rel="external">algorithm 1</a>). Blistering conditions may be divided in to generalized or localized disorders, and additional features such as the patient's age, blister characteristics, and the patient's drug history may also offer clues for diagnosis  (<a class="graphic graphic_table graphicRef55836" href="/z/d/graphic/55836.html" rel="external">table 3</a>). (See <a class="local">'Patient assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic tests </strong>– Diagnostic tests commonly utilized in the evaluation of blistering skin disorders include light microscopy, direct and indirect immunofluorescence studies, antigen-specific serologic studies, and microbiologic tests. The specific disorders considered in the differential diagnosis determine the selection of the most appropriate test(s). (See <a class="local">'Diagnostic tests'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Weedon D. The vesicobullous reaction pattern. In: Weedon's Skin Pathology, 3rd ed, Elsevier, 2010. p.123.</li><li><a class="nounderline abstract_t">Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011; 39:1521.</a></li><li><a class="nounderline abstract_t">Leung AKC, Barankin B, Leong KF. Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management. World J Pediatr 2018; 14:116.</a></li><li><a class="nounderline abstract_t">Sebaratnam DF, Murrell DF. Bullous systemic lupus erythematosus. Dermatol Clin 2011; 29:649.</a></li><li><a class="nounderline abstract_t">Frew JW, Murrell DF. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin 2011; 29:419.</a></li><li><a class="nounderline abstract_t">Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004; 9:29.</a></li><li><a class="nounderline abstract_t">Czernik A, Camilleri M, Pittelkow MR, Grando SA. Paraneoplastic autoimmune multiorgan syndrome: 20 years after. Int J Dermatol 2011; 50:905.</a></li><li><a class="nounderline abstract_t">Ioannides D, Lazaridou E, Rigopoulos D. Pemphigus. J Eur Acad Dermatol Venereol 2008; 22:1478.</a></li><li><a class="nounderline abstract_t">Schmidt E, della Torre R, Borradori L. Clinical features and practical diagnosis of bullous pemphigoid. Dermatol Clin 2011; 29:427.</a></li><li><a class="nounderline abstract_t">Tran JT, Mutasim DF. Localized bullous pemphigoid: a commonly delayed diagnosis. Int J Dermatol 2005; 44:942.</a></li><li><a class="nounderline abstract_t">Venning VA. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Dermatol Clin 2011; 29:453.</a></li><li><a class="nounderline abstract_t">Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol 2011; 64:1017.</a></li><li><a class="nounderline abstract_t">Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol 2011; 64:1027.</a></li><li><a class="nounderline abstract_t">Caux F. Diagnosis and clinical features of epidermolysis bullosa acquisita. Dermatol Clin 2011; 29:485.</a></li><li><a class="nounderline abstract_t">Sami N, Yeh SW, Ahmed AR. Blistering diseases in the elderly: diagnosis and treatment. Dermatol Clin 2004; 22:73.</a></li><li><a class="nounderline abstract_t">Toonstra J. Bullosis diabeticorum. Report of a case with a review of the literature. J Am Acad Dermatol 1985; 13:799.</a></li><li><a class="nounderline abstract_t">Romano C, Rubegni P, Ghilardi A, Fimiani M. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum. Mycoses 2006; 49:249.</a></li><li><a class="nounderline abstract_t">Bleasel NR, Varigos GA. Porphyria cutanea tarda. Australas J Dermatol 2000; 41:197.</a></li><li><a class="nounderline abstract_t">Green JJ, Manders SM. Pseudoporphyria. J Am Acad Dermatol 2001; 44:100.</a></li><li class="breakAll">McGovern TW. Dermatoses due to plants. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier Limited, 2008. p.243.</li><li><a class="nounderline abstract_t">Uzun S, Durdu M. The specificity and sensitivity of Nikolskiy sign in the diagnosis of pemphigus. J Am Acad Dermatol 2006; 54:411.</a></li><li><a class="nounderline abstract_t">Pohla-Gubo G, Hintner H. Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases. Dermatol Clin 2011; 29:365.</a></li></ol></div><div id="topicVersionRevision">Topic 13684 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Weedon D. The vesicobullous reaction pattern. In: Weedon's Skin Pathology, 3rd ed, Elsevier, 2010. p.123.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21358399" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29508362" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21925012" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Bullous systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21605807" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14870982" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Paraneoplastic pemphigus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21781058" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Paraneoplastic autoimmune multiorgan syndrome: 20 years after.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18637862" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pemphigus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21605808" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical features and practical diagnosis of bullous pemphigoid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16336529" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Localized bullous pemphigoid: a commonly delayed diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21605811" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Linear IgA disease: clinical presentation, diagnosis, and pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21571167" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21571168" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21605816" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Diagnosis and clinical features of epidermolysis bullosa acquisita.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15018011" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Blistering diseases in the elderly: diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3908510" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Bullosis diabeticorum. Report of a case with a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16681820" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11105361" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Porphyria cutanea tarda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11148469" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pseudoporphyria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11148469" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Pseudoporphyria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16488290" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The specificity and sensitivity of Nikolskiy sign in the diagnosis of pemphigus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21605801" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
